245 related articles for article (PubMed ID: 35454108)
1. A Structural Perspective on Calprotectin as a Ligand of Receptors Mediating Inflammation and Potential Drug Target.
Garcia V; Perera YR; Chazin WJ
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454108
[TBL] [Abstract][Full Text] [Related]
2. Involvement of Oxidative Stress in Protective Cardiac Functions of Calprotectin.
Rochette L; Dogon G; Rigal E; Zeller M; Cottin Y; Vergely C
Cells; 2022 Apr; 11(7):. PubMed ID: 35406797
[TBL] [Abstract][Full Text] [Related]
3. S100/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent manner.
Yan L; Mathew L; Chellan B; Gardner B; Earley J; Puri TS; Hofmann Bowman MA
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1399-411. PubMed ID: 24855059
[TBL] [Abstract][Full Text] [Related]
4. The roles of toll-like receptor 4, CD33, CD68, CD69, or CD147/EMMPRIN for monocyte activation by the DAMP S100A8/S100A9.
Möller A; Jauch-Speer SL; Gandhi S; Vogl T; Roth J; Fehler O
Front Immunol; 2023; 14():1110185. PubMed ID: 37056775
[TBL] [Abstract][Full Text] [Related]
5. RAGE and TLRs: relatives, friends or neighbours?
Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end-products and Porphyromonas gingivalis lipopolysaccharide increase calprotectin expression in human gingival epithelial cells.
Hiroshima Y; Sakamoto E; Yoshida K; Abe K; Naruishi K; Yamamoto T; Shinohara Y; Kido JI; Geczy CL
J Cell Biochem; 2018 Feb; 119(2):1591-1603. PubMed ID: 28771806
[TBL] [Abstract][Full Text] [Related]
7. Significance of S100A8, S100A9 and calprotectin levels in bladder cancer.
Yasar O; Akcay T; Obek C; Turegun FA
Scand J Clin Lab Invest; 2017 Oct; 77(6):437-441. PubMed ID: 28609200
[TBL] [Abstract][Full Text] [Related]
8. Calprotectin and the Initiation and Progression of Head and Neck Cancer.
Argyris PP; Slama ZM; Ross KF; Khammanivong A; Herzberg MC
J Dent Res; 2018 Jun; 97(6):674-682. PubMed ID: 29443623
[TBL] [Abstract][Full Text] [Related]
9. TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms.
Kovačić M; Mitrović-Ajtić O; Beleslin-Čokić B; Djikić D; Subotički T; Diklić M; Leković D; Gotić M; Mossuz P; Čokić VP
Cell Oncol (Dordr); 2018 Oct; 41(5):541-553. PubMed ID: 29946821
[TBL] [Abstract][Full Text] [Related]
10. Formation of Calprotectin Inhibits Amyloid Aggregation of S100A8 and S100A9 Proteins.
Baronaitė I; Šulskis D; Kopu Stas A; Tutkus M; Smirnovas V
ACS Chem Neurosci; 2024 May; 15(9):1915-1925. PubMed ID: 38634811
[TBL] [Abstract][Full Text] [Related]
11. S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.
Oesterle A; Bowman MA
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2496-507. PubMed ID: 26515415
[TBL] [Abstract][Full Text] [Related]
12. The crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins.
Korndörfer IP; Brueckner F; Skerra A
J Mol Biol; 2007 Jul; 370(5):887-98. PubMed ID: 17553524
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells.
Ma L; Sun P; Zhang JC; Zhang Q; Yao SL
Int J Mol Med; 2017 Jul; 40(1):31-38. PubMed ID: 28498464
[TBL] [Abstract][Full Text] [Related]
14. S100A9 induced inflammatory responses are mediated by distinct damage associated molecular patterns (DAMP) receptors in vitro and in vivo.
Chen B; Miller AL; Rebelatto M; Brewah Y; Rowe DC; Clarke L; Czapiga M; Rosenthal K; Imamichi T; Chen Y; Chang CS; Chowdhury PS; Naiman B; Wang Y; Yang D; Humbles AA; Herbst R; Sims GP
PLoS One; 2015; 10(2):e0115828. PubMed ID: 25706559
[TBL] [Abstract][Full Text] [Related]
15. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
[TBL] [Abstract][Full Text] [Related]
16. The antimicrobial heterodimer S100A8/S100A9 (calprotectin) is upregulated by bacterial flagellin in human epidermal keratinocytes.
Abtin A; Eckhart L; Gläser R; Gmeiner R; Mildner M; Tschachler E
J Invest Dermatol; 2010 Oct; 130(10):2423-30. PubMed ID: 20555353
[TBL] [Abstract][Full Text] [Related]
17. Alarming and Calming: Opposing Roles of S100A8/S100A9 Dimers and Tetramers on Monocytes.
Russo A; Schürmann H; Brandt M; Scholz K; Matos ALL; Grill D; Revenstorff J; Rembrink M; von Wulffen M; Fischer-Riepe L; Hanley PJ; Häcker H; Prünster M; Sánchez-Madrid F; Hermann S; Klotz L; Gerke V; Betz T; Vogl T; Roth J
Adv Sci (Weinh); 2022 Dec; 9(36):e2201505. PubMed ID: 36310133
[TBL] [Abstract][Full Text] [Related]
18. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.
Ehrchen JM; Sunderkötter C; Foell D; Vogl T; Roth J
J Leukoc Biol; 2009 Sep; 86(3):557-66. PubMed ID: 19451397
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells.
Nakajima Y; Inagaki Y; Kido J; Nagata T
Oral Dis; 2015 Apr; 21(3):328-34. PubMed ID: 25098709
[TBL] [Abstract][Full Text] [Related]
20. S100A9-induced release of interleukin (IL)-6 and IL-8 through toll-like receptor 4 (TLR4) in human periodontal ligament cells.
Gao H; Zhang X; Zheng Y; Peng L; Hou J; Meng H
Mol Immunol; 2015 Oct; 67(2 Pt B):223-32. PubMed ID: 26038301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
